Quotables
"It is my heart-warmed and world-embracing Christmas hope and aspiration that all of us, the high, the low, the rich, the poor, the admired, the despised, the loved, the hated, the civilized, the savage (every man and brother of us all throughout the whole earth), may eventually be gathered together in a heaven of everlasting rest and peace and bliss, except the inventor of the telephone. "
Mark Twain ; Christmas greetings, 1890
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6797283 | Gastric retention dosage form having multiple layers The present invention is directed to a multilayered dosage form which is adapted for retention in the stomach and useful for the prolonged delivery of an active agent to a fluid environment of use. The active agent dosage form is a multilayer core, often bilayer, fo... | 09/28/2004 |
| 6780851 | Composition for the prevention and/or treatment of disorders due to abnormal lipid metabolism, comprising propionyl l-carnitine and chitosan A composition is disclosed suitable for the prevention and/or treatment of disorders due to abnormal lipid metabolism, such as hypercholesterolaemia, atherosclerosis, hyperlipidaemia and obesity, and which can therefore take the form of a dietary supplement or of an... | 08/24/2004 |
| 6764692 | Method to treat laminitis and reduce dietary intake for horses A method of treating laminitis in a horse is disclosed, comprising administering to the horse a naturally chelated trace mineral composition; promoting healthy skin, hair and hoof tissue. A method of reducing dietary intake is also disclosed, comprising administerin... | 07/20/2004 |
| 6759437 | Comprehensive pharmacologic therapy for treatment of obesity including cysteine The comprehensive pharmacologic therapy for treatment of obesity including Cysteine is a procedure which involves the administration of a desired therapeutic range of Diethylpropion and/or Phentermine in combination with a SSRI medication and nutritional supplementa... | 07/06/2004 |
| 6759049 | Pharmaceutical or dietetic mushroom-based compositions The invention concerns the field of pharmaceutics and dietetics. More particularly, the invention concerns pharmaceutical and/or dietetic mushroom-based compositions, characterised in that they contain one or several edible mushrooms with therapeutic properties and ... | 07/06/2004 |
| 6733793 | Oral composition with insulin-like activities and methods of use An orally administered, novel dietary supplement or therapeutic composition capable of insulin-like activity in animals, preferably humans, is provided. Contained in the composition are therapeutically effective amounts of vanadyl sulfate, alpha-lipoic acid, taurine... | 05/11/2004 |
| 6734160 | Methods of treating diabetes mellitus with OB polypeptides The present invention relates generally to the control of body weight of animals including mammals and humans, and more particularly to materials identified herein as modulators of weight, and to the diagnostic and therapeutic uses to which such modulators may be pu... | 05/11/2004 |
| 6723737 | Methods, pharmaceutical and therapeutic compostions for administering adenosine The invention discloses methods for the chronic administration of adenosine, which contrary to the acute delivery of the drug by injection or infusion, acts in desensitizing adenosine receptors towards the action of adenosine. The methods and oral compositions of ad... | 04/20/2004 |
| 6716436 | Cosmetic composition for slimming containing L-arginine, an L-arginine analogue, or one of their derivatives, for topical application A cosmetic composition for slimming which includes, in combination with a cosmetically acceptable excipient, at least one compound having the formula (I) where R1 is a group bound by a peptidic bond and... | 04/06/2004 |
| 6706255 | Liquid pharmaceutical compositions comprising thyroid hormones Liquid pharmaceutical compositions comprising at least one thyroid hormone, ethanol, a pH adjusting agent, and water are disclosed. The compositions may be delivered by a metered dosage delivery system such as an aerosol or pump-action spray, and are useful in the t... | 03/16/2004 |
| 6696414 | Use of growth hormone in low dose The invention relates to treatment of patients in need of increasing insulin sensitivity by administration of growth hormone or analogues thereof, preferably human growth hormone, in a low dose and the use of growth hormone or analogues thereof, preferabl... | 02/24/2004 |
| 6656473 | Tryptophan source from plants and uses thereof Compositions are described comprising at least partially defatted meal from a plant source containing protein-bound tryptophan, preferably squash seeds, and, optionally, a carbohydrate source provided in an amount capable of facilitating transport of in v... | 12/02/2003 |
| 6652839 | Chewing gum with liquid medium A gum, lollipop and lozenge having at least two separate components, the first component having desirable taste characteristics and the second component having a diet control composition incorporated therein.... | 11/25/2003 |
| 6627206 | Method and apparatus for treating obesity and for delivering time-released medicaments An apparatus and method for treating obesity and for delivering time-released medicaments is described and which includes a plurality of space-filling portions which are sized to be received within a human patient's body and which come together in a patie... | 09/30/2003 |
| 6616940 | Process for decreasing adiposity using Vitamin A as a dietary supplement A process is provided for reducing adiposity in an animal such as a companion animal by feeding the animal an effective amount of Vitamin A for a time sufficient to reduce adiposity in the animal. Preferably, the such effective amount comprises from about... | 09/09/2003 |
| 6608064 | Pharmaceutical agents for the treatment of Parkinson's disease, ADHD and microadenomas The present invention is directed to the use of certain pyrido[1,2-a]-pyrazine derivatives, also described as bis-azabicyclic compounds and defined by the formula (I) herein, in the treatment of Parkinson's disease, attention deficit hyperactivity disorde... | 08/19/2003 |
| 6558657 | Lipase inhibiting polymers The invention features a method for treating obesity in a patient by administering to the patient a polymer that has been substituted with one or more groups that inhibit lipases, which are enzymes responsible for the hydrolysis of fat. The invention furt... | 05/06/2003 |
| 6552087 | Therapeutic agent comprising (+)-sibutramine The use of (+)-sibutramine in the treatment of depression, obesity, Parkinson's disease, cerebral function disorders and diabetes is described.... | 04/22/2003 |
| 6548551 | Comprehensive pharmacologic therapy for treatment of obesity The comprehensive pharmacologic therapy for treatment of obesity is a procedure which involves the administration of a desired therapeutic range of Diethylpropion and/or Phentermine in combination with a SSRI medication and nutritional supplementation for... | 04/15/2003 |
| 6541033 | Thermosensitive biodegradable hydrogels for sustained delivery of leptin The present invention relates generally to the development of pharmaceutical compositions which provide for sustained release of biologically active polypeptides. More specifically, the invention relates to the use of thermosensitive, biodegradable hydrog... | 04/01/2003 |
| 6528502 | Composition and method for improved carbohydrate management in mammals A nutritional supplement for use in managing carbohydrates and enhancing anabolism in mammals is described. The nutritional supplement contains regulated amounts of niacin, chromium, and vanadium, and optionally thiamin, riboflavin, magnesium, and zinc. T... | 03/04/2003 |
| 6515019 | Methods of providing symptomatic and prophylactic treatment for medical and neurological conditions Methods are disclosed for prophylactically and chronically preventing symptomatic depression, neuronal cell injury and cell death in systemic and neurological conditions, populations with cerebrovascular risk factors, and invasive vascular procedures, emp... | 02/04/2003 |
| 6476071 | Correcting polymorphic metabolic dysfunction with (-)-hydroxycitric acid A method whereby in an individual showing evidence of dysregulation of elements of the Polymorphic Metabolic Dysfunction (PMD), which is defined as the dysregulation of the metabolism of insulin, glucocorticoids, leptin, resistin and peroxisome proliferat... | 11/05/2002 |
| 6476059 | Use of polycyclic 2-aminothiazole systems for the treatment of obesity The invention relates to the use of polycyclic 2-aminothiazole systems and their physiologically tolerated salts and physiologically functional derivatives for the treatment of obesity. The treatment involves administration of a compound of formula I, ##S... | 11/05/2002 |
| 6468988 | Composition that regulates and diminishes appetite and methods relating thereto A balanced composition of complex carbohydrate, protein, simple sugars, and lipids in the weight proportion of 3:2:1:1 substantially reduces appetite, even though the caloric composition is very low (about 240 cal per serving). This composition substantia... | 10/22/2002 |
| 6458409 | Method for producing an easily digestible protein concentrate, a protein-rich food item and its use The dietetic food concentrate is a pourable powder containing soy protein, honey and at least 50% by weight of albumin so that it is easily digestible. It is made by mixing 1/3 to 6 percent by weight of lecithin with a protein-containing starting material... | 10/01/2002 |
| 6458842 | Liquid pharmaceutical compositions comprising thyroid hormones There is disclosed a liquid pharmaceutical composition comprising a therapeutic agent which comprises: one or more thyroid hormone or hormones; from about 40% to about 96% ethanol by volume; a pH adjusting agent so that the measured pH of the composition ... | 10/01/2002 |
| 6447818 | Compositions containing compounds with adrenergic activity and vegetable extracts of Crataegus and gingko biloba for the treatment of overweight and obesity Compositions containing compounds with adrenergic activity and an extract of Crataegus standardized in flavonoids, combined with an extract of Gingko biloba standardized in flavonglucosides in appropriate weight ratios are suitable for pharmaceutical admi... | 09/10/2002 |
| 6444709 | Heteroethylene compounds and pharmaceutical and cosmetic compositions containing same The invention relates to novel heteroethynylenic compounds having the general formula (I): ##STR1## as well as to the use of these compounds in pharmaceutical compositions intended for use in human or veterinary medicine (dermatological, rheumatic, r... | 09/03/2002 |
| 6432449 | Biodegradable sustained-release alginate gels The present invention relates to sustained-release formulations using biodegradable alginate delayed gels or particles and methods thereof.... | 08/13/2002 |
| 6420350 | Weight loss product Supplement compositions designed to support weight loss and increase energy.... | 07/16/2002 |
| 6420339 | Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility The present invention relates generally to the chemical modification of biologically active agents. More, specifically, the invention relates to a novel approach to engineer, through mutagenesis and site-directed chemical conjugation, specific, well-defin... | 07/16/2002 |
| 6403657 | Comprehensive pharmacologic therapy for treatment of obesity The comprehensive pharmacologic therapy for treatment of obesity is a procedure which involves the administration of a desired therapeutic range of Diethylpropion and/or Phentermine in combination with a SSRI medication and nutritional supplementation for... | 06/11/2002 |
| 6399089 | Compositions and methods for regulating metabolism and balancing body weight Compositions and methods for balancing body weight by inhibiting re-uptake of serotonin, regulating metabolism, potentiating insulin, and inhibiting lipogenesis, in a mammal. The compositions comprise chromium, fat-free cocoa powder, Hypericum perforatum ... | 06/04/2002 |
| 6365633 | Method of treating eating disorders A compound of formula I ##STR1## or a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optiona... | 04/02/2002 |
| 6352692 | Lipase inhibiting polymers The invention features a method for treating obesity in a patient by administering to the patient a polymer that has been substituted with one or more groups that inhibit lipases, which are enzymes responsible for the hydrolysis of fat. The invention furt... | 03/05/2002 |
| 6350730 | OB polypeptides and modified forms as modulators of body weight The present invention relates generally to the control of body weight of animals including mammals and humans, and more particularly to materials identified herein as modulators of body weight, and to diagnostic and therapeutic uses of such modulators. In... | 02/26/2002 |
| 6340482 | Methods for inducing weight loss in a human with materials derived from Citrus varieties Materials derived from Citrus plants can be administered orally to humans for the purpose of producing or maintaining weight loss as well as improving the person's physical performance and increasing the person's lean muscle mass. The Citrus materials inc... | 01/22/2002 |
| 6306430 | Process for decreasing adiposity using vitamin a as a dietary supplement A process is provided for reducing adiposity in an animal such as a companion animal by feeding the animal an effective amount of Vitamin A for a time sufficient to reduce adiposity in the animal. Preferably, the such effective amount comprises from about... | 10/23/2001 |
| 6270756 | Weight loss induced by alpha interferon and gamma interferon The invention is based on the discovery that substances which release ZAG proteins from lymphocytes also cause accelerated weight loss in humans. By administering an amount of the substance which is effective to cause the weight loss but is beneath an amo... | 08/07/2001 |
